Robert Ferris, Executive Director at UNC Lineberger Comprehensive Cancer Center, shared UNC Lineberger Comprehensive Cancer Center’s post on X, adding:
“Impressive result from a large drug screen driven by deep knowledge and harnessing of tumor biology, working to move therapeutics to the clinic as rapidly as possible!”
Quoting UNC Lineberger Comprehensive Cancer Center’s post:
“Researchers at UNC Lineberger have developed a small molecule that selectively degrades a protein implicated in Ewing sarcoma, a rare and aggressive cancer of the bone and soft tissue that primarily affects children and teenagers.
The preclinical study points to a potential new therapeutic approach for a disease with limited treatment options when standard therapies fail.”
See OncoDaily’s impactful insight about Ewing Sarcoma.
